Piu Medical SpA (FRA:IV3) Current Deferred Revenue: €0.00 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IV3 Piu Medical SpA FRA:IV3
14 GF Score
Price €5.45
! 5 Warning Signs
View Full Analysis

What is Piu Medical SpA Current Deferred Revenue?

Piu Medical SpA FRA:IV3 -2.68% 14 Current Deferred Revenue is €0.00 Mil as of Jun. 2025. GuruFocus rates FRA:IV3 with a GF Score™ of 14/100. The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Piu Medical SpA's current deferred revenue for the quarter that ended in Jun. 2025 was €0.00 Mil.

Piu Medical SpA Current Deferred Revenue Related Terms

Piu Medical SpA Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Piu Medical SpA's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piu Medical SpA Current Deferred Revenue Chart

Piu Medical SpA Annual Data
Trend Dec23 Dec24 Dec25
Current Deferred Revenue
0.00 0.00 0.00

Piu Medical SpA Semi-Annual Data
Dec23 Dec24 Jun25 Dec25
Current Deferred Revenue 0.00 0.00 0.00 0.00
FRA:IV3
14GF Score
Piu Medical SpA FRA:IV3
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of €0.00 Mil mean?
Piu Medical SpA (FRA:IV3) has a Current Deferred Revenue of €0.00 Mil as of Jun. 2025. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Piu Medical SpA and its competitors.
Is Piu Medical SpA's Current Deferred Revenue too high?
Piu Medical SpA's current Current Deferred Revenue is €0.00 Mil. Overall, Piu Medical SpA has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's Current Deferred Revenue compare to competitors?
Piu Medical SpA's Current Deferred Revenue of €0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Piu Medical SpA and its competitors. Piu Medical SpA's current Current Deferred Revenue is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (FRA:IV3) has a current Current Deferred Revenue of €0.00 Mil. The current Current Deferred Revenue is €0.00 Mil. Piu Medical SpA's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Piu Medical SpA (FRA:IV3), the current Current Deferred Revenue is €0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Piu Medical SpA Business Description

Other Exchanges PMED:Italy
Address Viale LombardiA 62, Castronno, ITA, IT-21040
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
14GF Score

Get the complete analysis for FRA:IV3

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.45
Price